The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats

被引:26
|
作者
Khayyal M.T. [2 ]
El-Ghazaly M.A. [1 ]
El-Hazek R.M. [1 ]
Nada A.S. [1 ]
机构
[1] Drug Radiation Research Department, National Centre for Radiation Research and Technology, Atomic Energy Authority, Cairo
[2] Pharmacology Department, Faculty of Pharmacy, Cairo University, Cairo
关键词
Acute inflammation; Celecoxib; Cyclooxygenase; Cytokines; Diclofenac; Prostanoids; Reactive oxygen species;
D O I
10.1007/s10787-009-0014-z
中图分类号
学科分类号
摘要
The potential value of selective and non-selective COX-2 inhibitors in preventing some of the biochemical changes induced by ionizing radiation was studied in rats exposed to carrageenan-induced paw edema and 6-day-old air pouch models. The animals were exposed to different exposure levels of γ-radiation, namely either to single doses of 2 and 7.5 Gy or a fractionated dose level of 7.5 Gy delivered as 0.5 Gy twice weekly for 7.5 weeks. The inflammatory response produced by carrageenan in irradiated rats was markedly higher than that induced in non-irradiated animals, and depended on the extent of irradiation. Celecoxib, a selective COX-2 inhibitor, in doses of 3, 5, 10, and 15 mg/kg was effective in reducing paw edema in irradiated and non-irradiated rats in a dose-dependent manner as well as diclofenac (3 mg/kg), a non-selective COX inhibitor. Irradiation of animals before the induction of the air pouch by an acute dose of 2 Gy led to a significant increase in leukocytic count, as well as in the level of interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), LTB4, PGE2 (as an index of COX-2 activity), TXB 2 (as an index of COX-1 activity), and the plasma level of MDA. This increase in level of these parameters was more marked than that observed in the non-irradiated animals subjected to the inflammagen. The blood GSH level was not affected by the dose of irradiation used, whereas superoxide dismutase (SOD) activity was suppressed. In many respects, celecoxib (5 mg/kg) was as potent as diclofenac in decreasing the elevated levels of IL-6, IL-1β, TNF-α, LTB4, PGE2, but lacked any significant effect on TXB 2 level. Since it is mostly selective for COX-2 with a rare effect on COX-1 enzyme, both drugs at the selected dose levels showed no effect on level of MDA, GSH, and SOD activity. © 2009 Birkhäuser Verlag, Basel/Switzerland.
引用
收藏
页码:255 / 266
页数:11
相关论文
共 50 条
  • [31] Wound collagen deposition in rats:: effects of an NO-NSAID and a selective COX-2 inhibitor
    Muscará, MN
    McKnight, W
    Asfaha, S
    Wallace, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (04) : 681 - 686
  • [32] PREVENTIVE EFFECTS OF COX-2 INHIBITOR, CELECOXIB ON RENAL TUBULAR INJURY INDUCED BY SHOCK WAVE LITHOTRIPTOR
    Park, Hyoung Keun
    Lee, Hae won
    Lee, Kwang Soo
    Kim, Hyeon Hoe
    JOURNAL OF UROLOGY, 2009, 181 (04): : 581 - 582
  • [33] Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling
    Kim, Nayoung
    Kim, Chung Hyun
    Ahn, Dong-Won
    Lee, Kyoung Soo
    Cho, Soo-Jeong
    Park, Ji Hyun
    Lee, Mi Kyoung
    Kim, Joo Sung
    Jung, Hyun Chae
    Song, In Sung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (03) : 480 - 487
  • [34] Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells
    Niederberger, E
    Manderscheid, C
    Grösch, S
    Schmidt, H
    Ehnert, C
    Geisslinger, G
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) : 341 - 350
  • [35] Rofecoxib: A selective COX-2 inhibitor
    不详
    Drugs & Therapy Perspectives, 2000, 15 (2) : 1 - 5
  • [36] Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway
    Miyamoto, Katsuichi
    Miyake, Sachiko
    Mizuno, Miho
    Oka, Nobuyuki
    Kusunoki, Susumu
    Yamamura, Takashi
    BRAIN, 2006, 129 : 1984 - 1992
  • [37] Inflammation induced cartilage damage is COX-2 mediated and can be prevented by celecoxib.
    Mastbergen, SC
    Lafeber, FPJG
    Bijlsma, JWJ
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S349 - S349
  • [39] Efficacy and safety of celecoxib, a specific COX-2 inhibitor, in osteoarthritis
    Geis, GS
    Hubbard, RC
    Woods, EM
    Yu, S
    Zhao, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S45 - S45
  • [40] Celecoxib: A COX-2 inhibitor for the treatment of osteoarthritis and rheumatoid arthritis
    Boyce, EG
    Breen, GA
    FORMULARY, 1999, 34 (05) : 405 - +